| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunome, Inc. (IMNM) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. IMNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $9.30M | - | |
| Dir | 341.1K | $8.81M | - | |
| Dir | 108.5K | $2.80M | - | |
| CFO | 94.5K | $2.44M | - | |
| Other | 76.5K | $1.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2021 | Lefenfeld Michael | Director | Buy | 4,650 | $18.53 | $86,149.65 | +6.6% | -29.8% | -83.4% | |
| May 26, 2021 | Rapp Michael | Director | Buy | 53,498 | $18.38 | $983,423.06 | +16.1% | -29.8% | -83.4% | |
| May 25, 2021 | Sarma Purnanand D | President And CEO | Buy | 10,500 | $18.41 | $193,305.00 | New | -24.2% | -83.8% | |
| May 24, 2021 | Wagenheim Philip | Director | Buy | 13,500 | $18.35 | $247,725.00 | +3.5% | -23.5% | -81.7% | |
| May 24, 2021 | Lamattina John L | Director | Buy | 5,440 | $18.57 | $101,027.88 | +5.8% | -23.5% | -81.7% | |
| Oct 6, 2020 | Rapp Michael | Director | Buy | 83,332 | $12.00 | $999,984.00 | +15.0% | - | - |